Explore a treatment option to improve glycemic control in adults with T2D and when you should consider using a GLP-1 RA. Join experts in T2D Aaron King, MD, Davida Kruger, MSN, APRN-BC, and Javier Morales, MD, as they review the disease state of T2D, the role of GLP-1 in glucose regulation, guidelines on early use of GLP-1 RAs in T2D treatment, as well as dosing, administration, and the monotherapy data of a once daily GLP-1 RA for T2D treatment.

This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

Faculty Presenters:

Aaron King, MD
Physician
Baptist Health System Physician
San Antonio, TX

Davida F. Kruger, MSN, APRN‐BC, BC‐ADM
Certified Nurse Practitioner
A Henry Ford Health System,
Division of Endocrinology, Diabetes,
Bone and Mineral Disorders
Detroit, MI

Javier Morales, MD, FACP, FACE
Associate Clinical Professor of Medicine
Hofstra Northwell
Huntington, NY